Dendreon’s Provenge gets recommendation in Europe

Eric Palmer

Dendreon today got the best news it has had in a long time for its prostate cancer vaccine , a thumbs up from the 's Committee for Medicinal Products for Human Use (CHMP) for approval in .

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS